NO953332D0 - Nye forbindelser - Google Patents
Nye forbindelserInfo
- Publication number
- NO953332D0 NO953332D0 NO953332A NO953332A NO953332D0 NO 953332 D0 NO953332 D0 NO 953332D0 NO 953332 A NO953332 A NO 953332A NO 953332 A NO953332 A NO 953332A NO 953332 D0 NO953332 D0 NO 953332D0
- Authority
- NO
- Norway
- Prior art keywords
- pct
- alkyl
- date
- fluoroalkyl
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/68—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C229/70—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
- C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9300657A SE9300657D0 (sv) | 1993-02-26 | 1993-02-26 | New compounds |
| PCT/SE1994/000152 WO1994019315A1 (en) | 1993-02-26 | 1994-02-24 | New compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO953332D0 true NO953332D0 (no) | 1995-08-24 |
| NO953332L NO953332L (no) | 1995-08-24 |
Family
ID=20389053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO953332A NO953332L (no) | 1993-02-26 | 1995-08-24 | Nye forbindelser |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5661183A (sv) |
| EP (1) | EP0686144B1 (sv) |
| JP (1) | JPH08507294A (sv) |
| CN (1) | CN1121344A (sv) |
| AT (1) | ATE191908T1 (sv) |
| AU (1) | AU6159994A (sv) |
| CZ (1) | CZ213995A3 (sv) |
| DE (1) | DE69424039D1 (sv) |
| FI (1) | FI954016A (sv) |
| HU (1) | HUT72992A (sv) |
| IS (1) | IS4133A (sv) |
| NO (1) | NO953332L (sv) |
| PL (1) | PL310398A1 (sv) |
| SE (1) | SE9300657D0 (sv) |
| SK (1) | SK96995A3 (sv) |
| WO (1) | WO1994019315A1 (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2509413C (en) | 2002-12-20 | 2012-05-01 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| BRPI0816767B8 (pt) | 2007-09-14 | 2021-05-25 | Addex Pharmaceuticals Sa | composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos |
| WO2010011871A2 (en) * | 2008-07-23 | 2010-01-28 | The Regents Of The University Of California | Methods and compositions for providing salicylic acid-independent pathogen resistance in plants |
| AU2009289784B2 (en) | 2008-09-02 | 2012-03-22 | Addex Pharma S.A. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| WO2010060589A1 (en) | 2008-11-28 | 2010-06-03 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MY161325A (en) | 2009-05-12 | 2017-04-14 | Janssen Pharmaceuticals Inc | 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| US8946205B2 (en) | 2009-05-12 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| PL2649069T3 (pl) | 2010-11-08 | 2016-01-29 | Janssen Pharmaceuticals Inc | Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2 |
| CN103261195B (zh) | 2010-11-08 | 2015-09-02 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| AU2011328203B2 (en) | 2010-11-08 | 2015-03-19 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| UA121965C2 (uk) | 2014-01-21 | 2020-08-25 | Янссен Фармацевтика Нв | Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування |
| KR102461134B1 (ko) | 2014-01-21 | 2022-10-28 | 얀센 파마슈티카 엔.브이. | 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0621083B2 (ja) * | 1986-12-22 | 1994-03-23 | 株式会社三光開発科学研究所 | ジ（アリ−ルオキシ）アルカンの製造方法 |
-
1993
- 1993-02-26 SE SE9300657A patent/SE9300657D0/sv unknown
-
1994
- 1994-02-21 IS IS4133A patent/IS4133A/is unknown
- 1994-02-22 CZ CZ952139A patent/CZ213995A3/cs unknown
- 1994-02-22 US US08/433,339 patent/US5661183A/en not_active Expired - Lifetime
- 1994-02-22 PL PL94310398A patent/PL310398A1/xx unknown
- 1994-02-22 CN CN94191796A patent/CN1121344A/zh active Pending
- 1994-02-22 AU AU61599/94A patent/AU6159994A/en not_active Abandoned
- 1994-02-22 SK SK969-95A patent/SK96995A3/sk unknown
- 1994-02-22 JP JP6518900A patent/JPH08507294A/ja active Pending
- 1994-02-22 HU HU9502491A patent/HUT72992A/hu unknown
- 1994-02-24 EP EP94908556A patent/EP0686144B1/en not_active Expired - Lifetime
- 1994-02-24 AT AT94908556T patent/ATE191908T1/de not_active IP Right Cessation
- 1994-02-24 DE DE69424039T patent/DE69424039D1/de not_active Expired - Lifetime
- 1994-02-24 WO PCT/SE1994/000152 patent/WO1994019315A1/en active IP Right Grant
-
1995
- 1995-08-24 NO NO953332A patent/NO953332L/no unknown
- 1995-08-25 FI FI954016A patent/FI954016A/sv unknown
-
1996
- 1996-12-20 US US08/770,488 patent/US5688945A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IS4133A (is) | 1994-08-27 |
| DE69424039D1 (de) | 2000-05-25 |
| AU6159994A (en) | 1994-09-14 |
| FI954016A0 (sv) | 1995-08-25 |
| FI954016A (sv) | 1995-08-25 |
| CZ213995A3 (en) | 1996-04-17 |
| US5661183A (en) | 1997-08-26 |
| HU9502491D0 (en) | 1995-10-30 |
| EP0686144A1 (en) | 1995-12-13 |
| PL310398A1 (en) | 1995-12-11 |
| ATE191908T1 (de) | 2000-05-15 |
| US5688945A (en) | 1997-11-18 |
| HUT72992A (en) | 1996-06-28 |
| WO1994019315A1 (en) | 1994-09-01 |
| EP0686144B1 (en) | 2000-04-19 |
| JPH08507294A (ja) | 1996-08-06 |
| SK96995A3 (en) | 1996-06-05 |
| CN1121344A (zh) | 1996-04-24 |
| NO953332L (no) | 1995-08-24 |
| SE9300657D0 (sv) | 1993-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953332D0 (no) | Nye forbindelser | |
| DE69305322D1 (de) | Salpetersäureester von 2-(2,6-dihalophenylamino)phenylessigsäurederivaten und verfahren zu ihrer herstellung | |
| RU94019984A (ru) | ПИРИДАЗИНЫ КАК ИНГИБИТОРЫ ИНТЕРЛЕЙКИН-1 β ПРЕОБРАЗУЮЩЕГО ФЕРМЕНТА, ФАРМКОМПОЗИЦИЯ НА ИХ ОСНОВЕ И ИХ ПРИМЕНЕНИЕ | |
| HUP0301249A2 (hu) | APO B termelődés gátló benzamid-vegyületek ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ATE377010T1 (de) | Caspase-inhibitoren und ihre verwendungen | |
| DK0696287T3 (da) | Ureido-derivater af naphthalenphosphonsyrer og fremgangsmåde til deres fremstilling | |
| ATE260257T1 (de) | Quinolinon derivate, verfahren zu ihrer herstellung und anti-allergisches wirkstoff | |
| HUP0204347A2 (en) | Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them and their use | |
| EA200100090A3 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| DE69129333D1 (de) | Diphenylpiperazinderivat und dieses enthaltendes arzneimittel für kreislauforgane | |
| EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
| ATE141606T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung | |
| PT874841E (pt) | Derivados da 1-benzenossulfonilpirrolidina como antagonistas do receptor da bradiquinina | |
| DE69624582D1 (de) | Ester und amide als pla2-inhibitoren | |
| ATE184593T1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
| DE69635057D1 (de) | Verfahren zur herstellung von campothecinderivate | |
| HUP0300177A2 (hu) | Szívszélhűdés ellen alkalmazható piridazinil-fenil-hidrazon-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| SE8501988D0 (sv) | Iminothiazolidine derivatives | |
| PE68299A1 (es) | 1,2,3,4-tetrahidroisoquinolinas terapeuticas | |
| CA2156079A1 (en) | Novel derivatives of 3-hydroxy anthranilic acid, methods and intermediates for their preparation, novel pharmaceutial compositions and the use thereof | |
| ATE189206T1 (de) | Neue verbindungen | |
| TH54292B (th) | กรรมวิธีสำหรับการเตรียม n-แอริล-แอนธรานิลิคแอซิด และอนุพันธ์ของสารเหล่านั้น | |
| JPS52254A (en) | Process for preparation of secopenicilanic acid amide derivatives |